Earnings Releases

Finance of America Companies Inc. reported the year ended December 31, 2025 results: revenue $2.4 billion, net income $110 million of net income from continuing operations, EPS $5.04 in basic earnings per share.

“the year, up 175% year over year – – $3.04 in adjusted earnings per share (1) or $74 million of adjusted net income (1) for the year, up 429% year over year – – Funded volume of $2.4 billion for the year, representing a 24% increase from 2024 – Plano, Texas (March 10, 2026): Finance of America Companies Inc. (“Finance of America” or the “Company”) (NYSE: FOA) , a”

Finance of America Companies Inc. reported the quarter ended December 31, 2025 results: revenue $619 million.

“Funded volume of $619 million for the quarter”

loanDepot, Inc. reported the fiscal year ended December 31, 2025 results: revenue $1.19 billion, net income Net loss of $108 million, EPS Diluted loss per share $ (0.30).

“loan origination volume since 2022. Grew market share 19% while investing in digital infrastructure to scale for growth. Full-year 2025 highlights: • Revenue increased 12% to $1.19 billion and adjusted revenue increased 10% to $1.21 billion compared to the prior quarter on higher pull-though weighted lock volume and margin. • Pull-through weighted gain on sale”

loanDepot, Inc. reported the quarter ended December 31, 2025 results: revenue $310 million, net income Net loss of $33 million, EPS Diluted loss per share $ (0.10).

“increased 23% to $8.04 billion, representing the highest level since 2022 and a 19% increase in market share to 1.4% 1 compared to the prior quarter. • Revenue decreased 4% to $310 million and adjusted revenue decreased 3% to $316 million compared to the prior quarter, reflecting lower pull-though weighted gain on sale margin. • Pull-through weighted gain on sale”

ImageneBio, Inc. reported financial results for the quarter and fiscal year ended December 31, 2025.

“On March 10, 2026, ImageneBio, Inc. (the “Company”) announced its financial results for the quarter and fiscal year ended December 31, 2025.”

Kodiak AI, Inc. reported fourth quarter and fiscal year ended December 31, 2025 results: revenue $1.1 million.

“Q4 Revenue of $1.1 million, representing 37% quarter-over-quarter growth”

Blend Labs, Inc. reported the first quarter of 2026 results: revenue $28.5M - $30.0M. Guidance initiated.

“Blend is providing guidance for the first quarter of 2026 as follows: $ in millions Q1 2026 Guidance Total Revenue $28.5M - $30.0M Non-GAAP Operating Income $2.0M - $3.0M”

Blend Labs, Inc. reported the fiscal year ended December 31, 2025 results: revenue $123.5 million, EPS $0.07.

“Full year revenue was $123.5 million, an increase of 7% compared to 2024. Software platform revenue was $114.4 million, up 7% year-over-year and Professional services revenue was $9.1 million compared to $8.8 million in 2024. Total GAAP gross profit margin was 74%, up from 72% in 2024, and non-GAAP gross profit margin was 77%, up from 73% in 2024. GAAP operating loss was $21.8 million, an improvement from a loss of $48.8 million in 2024. Non-GAAP operating income was $15.1 million, up from a loss of $12.8 million in 2024. GAAP diluted net loss from continuing operations attributable to common stockholders per share was $0.07 compared to a loss of $0.21 in 2024. Non-GAAP diluted net income from continuing operations attributable to common stockholders per share was $0.01 in 2025 compared to a loss of $0.10 in 2024.”

Blend Labs, Inc. reported the fourth fiscal quarter ended December 31, 2025 results: revenue $32.4 million, EPS $0.03.

“Fourth quarter revenue was $32.4 million, an increase of 7% compared to the fourth quarter of 2024. Software platform revenue was $30.3 million, up 10% year-over-year, and Professional services revenue was $2.1 million compared to $2.5 million in the fourth quarter of 2024. Total GAAP gross profit margin was 76%, up from 74% in the fourth quarter of 2024, and non-GAAP gross profit margin was 80%, up from 75% in the same period last year. GAAP operating loss was $3.6 million, compared to a loss of $3.3 million in the fourth quarter of 2024. Non-GAAP operating income was $5.4 million, up from $3.7 million in the same period last year. GAAP diluted net loss from continuing operations attributable to common stockholders per share was $0.03 compared to a loss of $0.03 in the fourth quarter of 2024. Non-GAAP diluted net income from continuing operations attributable to common stockholders per share was break-even ($0.00) in both the fourth quarter of 2025 and the same period last year.”

Cadre Holdings, Inc. reported Full Year 2026 results: revenue $736 to $758 Million. Guidance initiated.

“Expects Full Year 2026 Net Sales of $736 to $758 Million and Adjusted EBITDA of $136 to $141 Million, Reflecting Year-Over-Year Growth of 22% and 24%, Respectively, at Midpoints”

Cadre Holdings, Inc. reported the year ended December 31, 2025 results: revenue $610.3 million, net income $44.1 million, EPS $1.02 per diluted share.

“by specific reference in such filing. ​ --- EX-99.1 (EX-99.1) --- Cadre Holdings Reports Fourth Quarter and Full Year 2025 Financial Results ​ Generated Annual Net Sales of $610.3 Million, Gross Margin of 42.5% and Net Income of $44.1 Million ​ Achieved Record Annual Adjusted EBITDA for Third Consecutive Year ​ Expects Full Year 2026 Net Sales of $736 to $758”

Cadre Holdings, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $167.2 million, net income $11.7 million, EPS $0.27 per diluted share.

“For the quarter ended December 31, 2025, Cadre generated net sales of $167.2 million”

Rapport Therapeutics, Inc. reported financial results for the quarter and year ended December 31, 2025.

“On March 10, 2026, Rapport Therapeutics, Inc. (the “Company”) announced its financial results and business highlights for the quarter and year ended December 31, 2025.”

INFINITY NATURAL RESOURCES, INC. updated its Full Year 2026 guidance (initiated).

“Full Year 2026 Outlook • Development capital budget of $450 million to $500 million, including D&C and midstream”

INFINITY NATURAL RESOURCES, INC. reported the year ended December 31, 2025 results: net income $64.0 million.

“liquidity was $226.9 million as of December 31, 2025 and $413.1 million as of February 28, 2026 Full Year 2025 Highlights • Delivered 46% growth in total net daily production to 211.8 MMcfe/d, or 35.3 MBoe/d, in 2025 compared to 2024 • Reported net income of $64.0 million 1 • Delivered Adjusted EBITDAX (1) of $261.0 million, representing an Adjusted EBITDAX Margin (1) of $3.38 / Mcf, or $20.26 / Boe, which we believe is the best among our Appalachian Basin peers • Placed 23 wells into sales in 2025 totaling approximately 363,000 lateral feet comprised of (a) 11 oil-weighted wells in the volatile oil window of the Ohio Utica Shale and (b) 12 natural gas-weighted wells in the Marcellus Shale in Pennsylvania • Acquired approximately 6,700 net acres during the year • Generated $261.8 million of net cash provided by operating activities for the year ended December 31, 2025 • Development capi”

INFINITY NATURAL RESOURCES, INC. reported the quarter ended December 31, 2025 results: net income $80.4 million.

“nelian”) • Delivered 93% growth in total net daily production to 271.6 MMcfe/d, or 45.3 MBoe/d, in the fourth quarter 2025 compared to the fourth quarter 2024 • Increased natural gas net production 129% compared to fourth quarter 2024 • Reported net income of $80.4 million • Delivered 104% growth in Adjusted EBITDAX (1) to $94.0 million in the fourth quarter 2025 compared to the fourth quarter 2024, representing an Adjusted EBITDAX Margin (1) of $3.76 / Mcf, or $22.58 / Boe, which we believe is the best among our Appalachian Basin peers • Placed 6 wells into sales in the fourth quarter totaling approximately 103,000 lateral feet comprised of (a) 3 oil-weighted wells in the volatile oil window of the Ohio Utica Shale and (b) 3 natural gas-weighted wells in the Marcellus Shale in Pennsylvania • Acquired working interests in our South Bend Field in Pennsylvania (the "South Bend Acquisition"”

NATURES SUNSHINE PRODUCTS INC reported the full year ended December 31, 2025 results: revenue $480.1 million, net income $19.5 million, EPS $1.06 per diluted share.

“Net sales were up 5.7% to $480.1 million compared to $454.4 million (up 5.3% in constant currency). • GAAP net income attributable to common shareholders of $19.5 million, or $1.06 per diluted share, compared to $7.7 million, or $0.40 per diluted share.”

NATURES SUNSHINE PRODUCTS INC reported the fourth quarter ended December 31, 2025 results: revenue $123.8 million, net income $4.1 million, EPS $0.23 per diluted share.

“Net sales were up 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency). • GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.”

TENAX THERAPEUTICS, INC. reported year ended December 31, 2025 results: net income net loss of $52.6 million.

“Tenax Therapeutics reported a net loss of $52.6 million for the year ended December 31, 2025, compared to a net loss of $17.6 million for the year ended December 31, 2024.”

TENAX THERAPEUTICS, INC. reported fourth quarter ended December 31, 2025 results: net income net loss of $15.5 million.

“Tenax Therapeutics reported a net loss of $15.5 million for the fourth quarter of 2025, compared to a net loss of $6.3 million for the fourth quarter of 2024.”

VALHI INC /DE/ reported the full year of 2025 results: net income net loss attributable to Valhi stockholders of $57.6 million, EPS $2.02 per share.

“For the full year of 2025, Valhi reported a net loss attributable to Valhi stockholders of $57.6 million, or $2.02 per share, compared to net income of $108.0 million, or $3.79 per share, for the full year of 2024.”

VALHI INC /DE/ reported the fourth quarter of 2025 results: net income net loss attributable to Valhi stockholders of $53.2 million, EPS $1.86 per share.

“Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $53.2 million, or $1.86 per share, in the fourth quarter of 2025”

ABM INDUSTRIES INC /DE/ reported FISCAL FIRST QUARTER 2026 results: revenue $2.2 billion, net income $38.8 million, EPS $0.64 per diluted share. Guidance reaffirmed.

“ABM REPORTS FISCAL FIRST QUARTER 2026 RESULTS AND REAFFIRMS FISCAL 2026 OUTLOOK • Revenue was $2.2 billion, an increase of 6.1% over the prior year, including organic growth of 5.5% • Net income totaled $38.8 million, or $0.64 per diluted share, as compared to $43.6 million or $0.69 in the prior year • Adjusted net income was $50.4 million, or $0.83 per diluted share”

ULTRALIFE CORP reported the fourth quarter ended December 31, 2025 results: revenue $48.5 million, net income ($7.4) million, EPS ($0.45) per basic and diluted share.

“Ultralife Corporation (NASDAQ: ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: ● Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarter ● Gross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarter ● Operating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of one-time costs, compared to $1.5 million for the 2024 fourth quarter ● GAAP EPS of ($0.45), which includes ($0.57) for the intangible asset impairment charge net of the related tax benefits, compared to $0.01 for the 2024 fourth quarter”

Stagwell Inc updated its 2026 guidance (initiated).

“Guidance for 2026 of Total Net Revenue Growth of 8% to 12%; Adjusted EBITDA of $475 million to $525 million; Free Cash Flow Conversion of 50% to 60%”

Stagwell Inc updated its the three and twelve months ended December 31, 2025 guidance (reaffirmed).

“On March 10, 2026, Stagwell Inc. (the “Company”) issued a press release announcing its financial results for the three and twelve months ended December 31, 2025.”

KOHLS Corp reported the quarter and year ended January 31, 2026 results: revenue $5.0 billion, net income $125 million, EPS $1.07 per diluted share. Guidance initiated.

“2025 Results Comparisons refer to the 13-week period ended January 31, 2026 versus the 13-week period ended February 1, 2025 • Net sales decreased 3.9% year-over-year, to $5.0 billion, with comparable sales down 2.8%. • Gross margin as a percentage of net sales was 33.1%, an increase of 25 basis points. • Selling, general & administrative (SG&A) expenses”

CONSUMER PORTFOLIO SERVICES, INC. reported twelve months ended December 31, 2025 results: revenue $434.5 million, net income $19.3 million, EPS $0.80 per diluted share.

“for the fourth quarter of 2025 was $7.2 million, compared to $7.4 million in the fourth quarter of 2024. For the twelve months ended December 31, 2025, total revenues were $434.5 million, an increase of approximately $41.0 million, or 10.4% compared to $393.5 million for the twelve months ended December 31, 2024. The $41.0 million increase in total revenue was”

CONSUMER PORTFOLIO SERVICES, INC. reported fourth quarter ended December 31, 2025 results: revenue $109.4 million, net income $5.0 million, EPS $0.21 per diluted share.

“Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $5.0 million, or $0.21 per diluted share, for its fourth quarter ended December 31, 2025. Total revenues for the fourth quarter of 2025 were $109.4 million”

FRANKLIN STREET PROPERTIES CORP /MA/ reported the fourth quarter and full year ended December 31, 2025 results: net income GAAP net loss was $7.3 million and $45.0 million, or $0.07 and $0.43 per basic and diluted share for the three and twelv, EPS $0.07 and $0.43 per basic and diluted share.

“On March 9, 2026, Franklin Street Properties Corp. (the “Registrant”) announced its financial results for the fourth quarter and full year ended December 31, 2025.”

MACROGENICS INC reported the year ended December 31, 2025 results: revenue $149.5 million.

“cash equivalents and marketable securities balance as of December 31, 2025, was $189.9 million, compared to $201.7 million as of December 31, 2024. • Revenue : Total revenue was $149.5 million for the year ended December 31, 2025, compared to $150.0 million for the year ended December 31, 2024. Total revenue included contract manufacturing revenue of $52.6 million for”

KRONOS WORLDWIDE INC reported the full year of 2025 results: revenue $1.9 billion, net income net loss of $110.9 million, EPS $.96 per share.

“in LPC as a result of the acquisition. Net sales of $418.3 million in the fourth quarter of 2025 were $4.8 million, or 1%, lower than in the fourth quarter of 2024. Net sales of $1.9 billion for the full year of 2025 were $27.7 million, or 1%, lower than the full year of 2024. Net sales decreased in the fourth quarter of 2025 compared to the fourth quarter of 2024”

KRONOS WORLDWIDE INC reported the fourth quarter of 2025 results: revenue $418.3 million, net income net loss of $82.8 million, EPS $.72 per share.

“million ($50.9 million, or $.44 per share, net of income tax expense) associated with the remeasurement of our investment in LPC as a result of the acquisition. Net sales of $418.3 million in the fourth quarter of 2025 were $4.8 million, or 1%, lower than in the fourth quarter of 2024. Net sales of $1.9 billion for the full year of 2025 were $27.7 million, or 1%,”

W&T OFFSHORE INC reported preliminary financial results for the year ended December 31, 2025.

“W&T Offshore, Inc. (the “Company”) is furnishing certain preliminary estimated information regarding the financial and operational results for the year ended December 31, 2025”

Stereotaxis, Inc. reported the fourth quarter and full year ended December 31, 2025 results: revenue $8.6 million, net income ($5.5) million.

“will increasingly reach development, regulatory and commercial milestones.” 2025 Fourth Quarter and Full Year Financial Results Revenue for the fourth quarter of 2025 totaled $8.6 million, a 36% increase compared to $6.3 million in the prior year fourth quarter. System revenue for the quarter was $3.3 million and recurring revenue was $5.3 million, compared to”

FreightCar America, Inc. updated its the fourth quarter and full year ended December 31, 2025 guidance (initiated).

“On March 9, 2026, FreightCar America, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025, and provided its financial outlook for the full year 2026.”

Byrna Technologies Inc. reported fiscal first quarter ended February 28, 2026 results: revenue $29.0 million.

“and --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ex_930029.htm EXHIBIT 99.1 ex_930029.htm Exhibit 99.1 Byrna Technologies Announces Preliminary Fiscal First Quarter Revenues of $29.0 Million ANDOVER, Mass., March 9, 2026 - Byrna Technologies Inc. ( “ Byrna ” or the “ Company ” ) (Nasdaq: BYRN), a personal defense technology company specializing in the development,”

MYOMO, INC. updated its the three months and year ended December 31, 2025 guidance (initiated).

“On March 9, 2026, Myomo, Inc, (the "Company") announced its financial results for the fourth quarter and full year ended December 31, 2025.”

BCP Investment Corp reported financial results for fiscal quarter ended December 31, 2025.

“On March 5, 2026, BCP Investment Corporation (the “Company”) issued a press release announcing its financial results for the fiscal year and fiscal quarter ended December 31, 2025.”

BCP Investment Corp reported financial results for fiscal year ended December 31, 2025.

“On March 5, 2026, BCP Investment Corporation (the “Company”) issued a press release announcing its financial results for the fiscal year and fiscal quarter ended December 31, 2025.”

GREENLIGHT CAPITAL RE, LTD. reported the year ended December 31, 2025 results: net income Net income of $74.8 million, or $2.17 per diluted ordinary share, EPS $2.17 per diluted ordinary share.

“Greenlight Capital Re, Ltd. (the "Registrant" or "Company") issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025.”

GREENLIGHT CAPITAL RE, LTD. reported the fourth quarter ended December 31, 2025 results: net income Net income of $49.3 million, or $1.44 per diluted ordinary share, EPS $1.44 per diluted ordinary share.

“Greenlight Capital Re, Ltd. (the "Registrant" or "Company") issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2025.”

ZEVRA THERAPEUTICS, INC. reported the full year ended December 31, 2025 results: revenue $106.5 million, net income Net income of $83.2 million, EPS $1.40 per basic and $1.35 per diluted share.

“--- Zevra Reports Fourth Quarter and Full Year 2025 Financial Results Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY 2025 net revenue of $106.5 million , driven by growth in MIPLYFFA ® net revenue to $87.4 million 2025 EPS of $1.40 basic and $1.35 diluted Company to host conference call and webcast TODAY, March 9, 2026, at 4:30”

ZEVRA THERAPEUTICS, INC. reported the fourth quarter ended December 31, 2025 results: revenue $34.1 million.

“Zevra Reports Fourth Quarter and Full Year 2025 Financial Results Q4 net revenue of $34.1 million”

Cartesian Therapeutics, Inc. reported financial results for the year ended December 31, 2025.

“On March 9, 2026, Cartesian Therapeutics, Inc. (the “Company”) announced its financial results for the year ended December 31, 2025.”

Fluent, Inc. reported full year 2026 results: revenue double-digit revenue growth on aggregate continuing business, net income adjusted EBITDA improvement for full year 2026. Guidance reaffirmed.

“Expect double-digit revenue growth on aggregate continuing business and adjusted EBITDA improvement for full year 2026”

Fluent, Inc. reported FY 2025 results: revenue Revenue of $208.8 million, net income Net loss of $27.2 million, EPS $1.05 per share.

“• Revenue of $61.8 million for Q4 2025 and $208.8 million for FY 2025 • Q4 2025 Commerce Media Solutions revenue grew 101% to $34.7 million (56% of consolidated revenue) from $17.2 million (26% of revenue) in Q4 2024 with gross profit margin (exclusive of depreciation and amortization) of 33% in Q4 2025 compared to 30% for the consolidated business • Commerce Media Solutions annual revenue run rate now exceeds $105 million, with media margin of 30% reflecting a sequential improvement of $20 million and five basis points, respectively, compared to Q3 2025 • Expect double-digit revenue growth on aggregate continuing business and adjusted EBITDA improvement for full year 2026”

Fluent, Inc. reported Q4 2025 results: revenue Revenue of $61.8 million, net income Net loss of $4.1 million, EPS $0.13 per share.

“Fluent Announces Unaudited Fourth Quarter and Full-Year 2025 Financial Results; Commerce Media Solutions Revenue Run Rate Exceeds $105 Million and Represents 56% of Consolidated Enterprise Revenue • Revenue of $61.8 million for Q4 2025 and $208.8 million for FY 2025 • Q4 2025 Commerce Media Solutions revenue grew 101% to $34.7 million (56% of consolidated revenue) from $17.2 million (26% of revenue) in Q4 2024 with gross profit margin (exclusive of depreciation and amortization) of 33% in Q4 2025 compared to 30% for the consolidated business • Commerce Media Solutions annual revenue run rate now exceeds $105 million, with media margin of 30% reflecting a sequential improvement of $20 million and five basis points, respectively, compared to Q3 2025 • Expect double-digit revenue growth on aggregate continuing business and adjusted EBITDA improvement for full year 2026 New York, NY – March 9, 2026 – Fluent, Inc. (NASDAQ: FLNT), a commerce media solutions company, today reported unaudited”

enCore Energy Corp. reported year ended December 31, 2025 results: EPS $(0.30).

“• Net loss per share $(0.30) versus $(0.34) for the year ended December 31, 2024;”

Coherus Oncology, Inc. reported the years ended December 31, 2025 results: revenue $42.2 million.

“Net revenue from continuing operations was $12.7 million and $7.7 million during the three months ended December 31, 2025 and 2024, respectively, and $42.2 million and $26.4 million during the years ended December 31, 2025 and 2024, respectively.”